Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Halozyme's PEGPH20 Program Gains Fast Track Designation
Halozyme's PEGPH20 Program Gains Fast Track Designation
Halozyme's PEGPH20 Program Gains Fast Track Designation
Submitted by
admin
on September 6, 2014 - 9:18am
Source:
Yahoo/Zacks
News Tags:
Halozyme
PEGPH20
metastatic pancreatic cancer
pancreatic cancer
Headline:
Halozyme's PEGPH20 Program Gains Fast Track Designation
Do Not Allow Advertisers to Use My Personal information
